Medications for hypertension of hemodialysis patients in Cáceres - Mato Grosso, Brazil: DOI: 10.15343/0104-7809.20184201158180

Blood pressure in hemodialysis patients is difficult to control. The adequate use of antihypertensive drugs, associated with a good control of blood volume, are the most appropriate measures for the control of blood pressure in these patients. to objective describe the main drug classes used to cont...

ver descrição completa

Detalhes bibliográficos
Autores: Vilella Hartwig, Shaiana, Lescano de Sousa Junior, Alcione, Ignotti, Eliane
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2018
País:Brasil
Recursos:Centro Universitário São Camilo
Repositório:O Mundo da Saúde (Online)
Idioma:português
OAI Identifier:oai:ojs3.revistamundodasaude.emnuvens.com.br:article/147
Acesso em linha:https://revistamundodasaude.emnuvens.com.br/mundodasaude/article/view/147
Access Level:Acceso aberto
Palavra-chave:Hipertensão. Diálise renal. Perfil de saúde.
Hypertension, Kidney dialysis, Health profile.
Descrição
Resumo:Blood pressure in hemodialysis patients is difficult to control. The adequate use of antihypertensive drugs, associated with a good control of blood volume, are the most appropriate measures for the control of blood pressure in these patients. to objective describe the main drug classes used to control hypertension and to describe the epidemiological profile of chronic kidney disease patients on hemodialysis in the city of Cáceres-MT in the year 2014. Descriptive, cross-sectional epidemiological study with patients underwent hemodialysis in 2014 in the city of Cáceres, by means of patient medical records of a total of 17,134 hemodialysis sessions with 133 patients. The majority were male, black, married, with a mean age of 55 years, with hypertensive nephrosclerosis as the underlying disease. The main comorbidity was diabetes mellitus; 80% are diagnosed of end-stage chronic kidney disease; the mean time on hemodialysis (survival) was 4.8 years and 78.6% were hypertensive. Among hypertensive patients, 41.8% used a combination of two antihypertensive drugs and 32.6% used monotherapy; the adrenergic inhibitors class used was 27.1%, and 12.5% received diuretics. There was a mean survival of 5.2 years for hypertensive patients. The drug therapy used to control blood pressure complies with international recommendations in 81.6% of cases. The characteristics of patients being treated are similar to the other cities in the country. The mean survival of the hypertensive group of patients was higher than that of the non-hypertensive group.